AssetMark Inc’s MacroGenics MGNX Stock Holding History

AssetMark Inc’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19	Buy	+5	New	+$21	﹤0.01%	3748

Other funds holding MGNX

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return

Lantern Wealth Advisors Melville, New York $232M AUM 16.88% 1-Year Est. Return

XML Financial Bethesda, Maryland $1.39B AUM 19.06% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

AssetMark Inc's MGNX Position: Q3 2026 in Review

AssetMark Inc opened a new position in MacroGenics (MGNX) in Q3 2026: 5 shares worth $19. The stake represents ﹤0.01% of the portfolio and ranks #3748 among its holdings.

26 funds tracked by Wall St. Rank hold MGNX as of Q3 2026.

AssetMark Inc held 5 shares of MacroGenics worth $19 as of Q3 2026.
MacroGenics was a new AssetMark Inc position in Q3 2026.
MacroGenics made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3748 holding.
26 funds tracked by Wall St. Rank held MacroGenics as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.